RASSF1Apromoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
Citations Over TimeTop 10% of 2017 papers
Abstract
The RASSF1A promoter is frequently methylated in high-grade serous ovarian cancer (HGSC). We examined RASSF1A promoter methylation in primary tumors, adjacent morphologically tumor cell-free tissues and corresponding circulating tumor DNA (ctDNA) samples of patients with HGSC, using a real-time methylation specific PCR (real-time MSP) and a methylation-sensitive high-resolution melting analysis (MS-HRMA) assay for the detection and semi-quantitative estimation of methylation, respectively. Two groups of primary HGSC tumor FFPE samples were recruited (Group A n=67 and Group B n=61), along with matched adjacent morphologically tumor cell-free tissues (n=58) and corresponding plasma samples (n=59) for group B. Using both assays, RASSF1A promoter was found highly methylated in primary tumors of both groups, and at lower percentages in the adjacent morphologically tumor cell-free tissues. Interestingly, RASSF1A promoter methylation was also observed in ctDNA by real-time MSP. Overall survival (OS) was significantly associated with RASSF1A promoter methylation in primary tumor samples using MS-HRMA (P=0.023). Our results clearly indicate that RASSF1A promoter is methylated in adjacent tissue surrounding the tumor in HGSC patients. We report for the first time that RASSF1A promoter methylation provides significant prognostic information in HGSC patients.
Related Papers
- → Effects of Particulate Matter on Genomic DNA Methylation Content and iNOS Promoter Methylation(2008)340 cited
- → Global methylation profiles in DNA from different blood cell types(2011)132 cited
- → Progressive age-dependent DNA methylation changes start before adulthood in mouse tissues(2010)47 cited
- → Changes of DNA methylation of Isoetes sinensis under Pb and Cd stress(2018)15 cited
- → Methylation levels assessment with Methylation-Sensitive High-Resolution Melting (MS-HRM)(2022)11 cited